The effectiveness of new migraine treatments has been compared to paracetamol in a new study, which suggests drugs developed in the 1990s should be more widely promoted to patients with the ...

一项对137项临床试验的元分析发现，尽管较少使用，Triptan (曲普坦)类药物在治疗偏头痛方面比新型药物更为有效，而后者价格更高。研究显示，尽管Triptan药物专为治疗偏头痛设计，但使用率不到22%。牛津大学的Andrea Cipriani建议，如果患者没有心血管疾病等禁忌症，低成本的Triptan应作为偏头痛的首选治疗药物。

An analysis highlights the superiority of triptans such as eletriptan and rizatriptan over newer migraine drugs and common ...

Oxford University scientists reviewed 89,000 patients in clinical trials given 17 different pills for migraine attacks and ...

Objective: To compare the effects of rizatriptan and patients' usual migraine medication(s) on health-related quality of life. Design and Setting: The study was a non-blinded, parallel-group ...

Migraines affect an estimated 190,000 people in the UK every day and many take some form of medication to combat pain that ...

A major new study has suggested the group of drugs called triptans are the most effective medicine for adults experiencing ...

New, more expensive migraine drugs are no more effective against the throbbing headaches than traditional painkillers, and ...

The comparative efficacy and tolerability of oral migraine medications suggest four triptans are superior to the newer, more ...

The newer and more expensive drugs rimegepant and ubrogepant — as well as another called lasmiditan, which can have drowsy ...

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the ...

Headaches affect about 40% of people globally, with migraines being the most common type.It is more common in women than men, ...